JIPOAd
JIPOAd
PARP
ESID
  • Users Online: 314
  • Print this page
  • Email this page
LETTER TO THE EDITOR
Year : 2019  |  Volume : 2  |  Issue : 4  |  Page : 129

In the era of immune checkpoint inhibitor therapy, can we safely expand to patients with immunodeficiency?


1 Department of Hematology and Medical Oncology, School of Medicine, Emory University; Winship Cancer Institute of Emory University, Atlanta, GA, USA
2 UC San Diego School of Medicine, San Diego, CA, USA

Correspondence Address:
Dr. Razelle Kurzrock
UC San Diego School of Medicine, San Diego, CA
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JIPO.JIPO_20_19

Get Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed545    
    Printed28    
    Emailed0    
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal